# David Schlanger

> David J. Schlanger is executive chairman of Progyny, where he was CEO from January 2017 through December 2021 and led the company through its 2019 IPO. Previously CEO of WebMD, he began his career in corporate law and developed a specialization in acquisitions, partnerships and corporate development.

- **Role:** Executive Chairman at Progyny, Inc.
- **Organizations:** Progyny, Inc., WebMD, Nox Health, Latham & Watkins, Medco Containment Services, Merck & Co., Synetic Inc.
- **Education:** B.S. (as identified in Progyny SEC filings), Georgetown University, J.D., University of Michigan Law School
- **Known for:** Led Progyny through its October 2019 IPO., Served as Progyny CEO during its April 2021 addition to the S&P MidCap 400., Previously led WebMD as CEO from August 2013 to September 2016.

## Career timeline

- **1984** — Graduated from University of Michigan Law School; began his career in corporate law at Latham & Watkins.
- **Before 2001** — Held acquisitions and business development roles at Medco Containment Services, Merck and Synetic.
- **2001** — Began working at WebMD in corporate development.
- **2013-05** — Became interim CEO of WebMD.
- **2013-08** — Named permanent CEO of WebMD.
- **2016-09** — Left WebMD by mutual agreement; Steven Zatz succeeded him.
- **2016-12** — Progyny announced his appointment as CEO on December 16.
- **2017-01** — Began CEO tenure at Progyny.
- **2017-03** — Joined Progyny’s board.
- **2019-10** — Led Progyny through its IPO and rang Nasdaq’s opening bell on October 25.
- **2021-04** — Progyny joined the S&P MidCap 400 during his CEO tenure.
- **2022-01** — Became executive chairman; Pete Anevski succeeded him as CEO.
- **2023-11** — Nox Health announced his appointment to its board.

## Achievements

- Led Progyny through its October 2019 IPO.
- Served as Progyny CEO during its April 2021 addition to the S&P MidCap 400.
- Previously led WebMD as CEO from August 2013 to September 2016.

## Latest updates

- **2026-03** — Progyny’s 2026 proxy statement continued to identify Schlanger as executive chairman.
- **2023-11** — Nox Health announced that Schlanger joined its board of directors.

## Links

- LinkedIn: https://www.linkedin.com/in/david-schlanger-82b05919

---

Profile page: https://yespress.io/david-schlanger
Published by YesPress — https://yespress.io
Last updated: 2026-10-14